Workshop Overview
Health economics plays an ever growing and important role in reimbursement decisions in Australia and internationally. The workshop is designed for professionals working in the pharmaceutical and healthcare technology industries who have not yet been involved in the reimbursement process.
Participants will gain an understanding of economic concepts and a practical insight into preparing a health economic evaluation. For those in the reimbursement industry, this practical insight will be transferrable to their own projects. For those willing to learn more about the reimbursement industry this workshop will provide the participant with an understanding of the challenges faced by their health economics colleagues and they will be better equipped to provide input into reimbursement applications.
Dominic Tilden
Dominic is the director of THEMA Consulting Pty LTd. A leading health economics consultancy based in Sydney Australia. As director of THEMA, Dominic Tilden is a health economist with over 12 years' practical experience in the design, development and implementation of health economic evaluations. Dominic has been an integral component of teams developing reimbursement applications across the world. He has developed and implemented creative and analytical strategies, managed multi-disciplinary teams and prepared submission dossiers for the communication of health economic arguments to reimbursement authorities in Australia, England, Wales, Scotland and many European countries. Since 1999, Dominic has been involved in over 100 submissions to the PBAC and over 50 submissions to reimbursement authorities around the world.
The workshop is intended to be a practical session, targeting personnel in health economics and regulatory departments involved in submissions to the PBAC or those wanting to understand particular inputs in a submission. The workshop will be of interest to managers of other departments such as marketing and clinical research who will benefit from understanding particular inputs and requirements for applications to the PBAC. The overall intention of the workshop is to enable attendees to gain an understanding of the process flow for an application to the PBAC, key inputs required in the application, particular requirements in the translation of clinical evidence into cost-effective outcomes. The session will include hypothetical and real-world examples, providing familiarity with current submission guidelines. The workshop is intended to be an introductory workshop for those new to this area of the pharmaceutical and/or medical device industries, or wanting to become involved in submissions to the PBAC.
Upon completion of this workshop, attendees will receive 6.5 CPD points
There are no specific entry criteria for this workshop. If you have any questions on your suitability for this workshop, please call the ARCS Office (02) 8905 0829.
Workshop fees (incl. GST):
Early bird offer available for the event, but it can only be claimed up to 28 days prior to the event.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
"Thanks - great session and you were very informative." Business Development Associate, Aspen Pharmacare
"An excellent course which was very well presented - thanks!" Regulatory Affairs Manager, Alcon Laboratories
If you're interested in taking this course, please provide your information below, and we'll inform you about the upcoming session's schedule.